{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:55:22Z","timestamp":1770238522828,"version":"3.49.0"},"reference-count":40,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T00:00:00Z","timestamp":1236816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Algorithms"],"abstract":"<jats:p>With the discovery of insulin came a deeper understanding of therapeutic options for one of the most devastating chronic diseases of the modern era, diabetes mellitus. The use of insulin in the treatment of diabetes, especially in those with severe insulin deficiency (type 1 diabetes), with multiple injections or continuous subcutaneous infusion, has been largely successful, but the risk for short term and long term complications remains substantial. Insulin treatment decisions are based on the patient\u2019s knowledge of meal size, exercise plans and the intermittent knowledge of blood glucose values. As such, these are open loop methods that require human input. The idea of closed loop control of diabetes treatment is quite different: automated control of a device that delivers insulin (and possibly glucagon or other medications) and is based on continuous or very frequent glucose measurements. Closed loop insulin control for type 1 diabetes is not new but is far from optimized. The goal of such a system is to avoid short-term complications (hypoglycemia) and long-term complications (diseases of the eyes, kidneys, nerves and cardiovascular system) by mimicking the normal insulin secretion pattern of the pancreatic beta cell. A control system for automated diabetes treatment consists of three major components, (1) a glucose sensing device that serves as the afferent limb of the system; (2) an automated control unit that uses algorithms which acquires sensor input and generates treatment outputs; and (3) a drug delivery device (primarily for delivery of insulin), which serves as the system\u2019s efferent limb. There are several major issues that highlight the difficulty of interacting with the complex unknowns of the biological world. For example, development of accurate continuous glucose monitors is crucial; the state of the art in 2009 is that such devices sometimes experience drift and are intended only to supplement information received from standard intermittent blood glucose data. In addition, it is important to acknowledge that an \u201cautomated\u201d closed loop pancreas cannot approach the complexity of the normal human endocrine pancreas, which takes continuous data from substrates, hormones, paracrine compounds and autonomic neural inputs, and in response, secretes four hormones. Another major issue is the substantial absorption\/action delay of insulin given by the subcutaneous route. Because of this delay, some researchers have recently given a portion of the meal-related insulin in an open loop manner before the meal and found this hybrid approach to be superior to closed loop control. Proportional-Integral-Derivative (PID) systems adapted from the industrial sector utilize control algorithms that alter output based on proportional (difference between actual and target levels), derivative (rate of change) and integral (time-related summative) errors in glucose. These algorithms have proven to be very promising in limited clinical trials. Related algorithms include a \u201cfading memory\u201d system that combines the proportional-derivative components of a classic PID system with time-relating decay of input signals that allow greater emphasis on more recent glucose values, a characteristic noted in mammalian beta-cells. Model Predictive Control (MPC) systems are highly adaptive methods that utilize mathematical models based on observations of biological behavior patterns using system identification and are now undergoing testing in humans. The application of further mathematical models, such as fuzzy control and artificial neural networks, are also promising, but are largely clinically untested. In summary, the prospects for closed loop control of glycemia in persons with diabetes have improved considerably. Major limitations include the delayed absorption\/action of subcutaneous insulin and the imperfect stability of currently-available continuous glucose sensors. The potential for improved glycemic control in persons with diabetes brings with it the potential for reduction in the frequency of acute and chronic complications of diabetes.<\/jats:p>","DOI":"10.3390\/a2010518","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T13:03:00Z","timestamp":1236949380000},"page":"518-532","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["A Review of Closed-Loop Algorithms for Glycemic Control in the Treatment of Type 1 Diabetes"],"prefix":"10.3390","volume":"2","author":[{"given":"Joseph","family":"El Youssef","sequence":"first","affiliation":[{"name":"Schnitzer Diabetes Center, mailstop OP05-DC, Oregon Health and Science University. 3181 SW Sam Jackson Park Road, Portland OR 97239, USA"}]},{"given":"Jessica","family":"Castle","sequence":"additional","affiliation":[{"name":"Schnitzer Diabetes Center, mailstop OP05-DC, Oregon Health and Science University. 3181 SW Sam Jackson Park Road, Portland OR 97239, USA"}]},{"given":"W. Kenneth","family":"Ward","sequence":"additional","affiliation":[{"name":"Schnitzer Diabetes Center, mailstop OP05-DC, Oregon Health and Science University. 3181 SW Sam Jackson Park Road, Portland OR 97239, USA"}]}],"member":"1968","published-online":{"date-parts":[[2009,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2008). Economic costs of diabetes in the US in 2007. Diabetes Care, 31, 1\u201320.","DOI":"10.2337\/dc08-9017"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 329, (14), 977\u201386.","DOI":"10.1056\/NEJM199309303291401"},{"key":"ref_3","first-page":"1281","article-title":"Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. 1922","volume":"145","author":"Banting","year":"1922","journal-title":"Cmaj"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/152091504774197990","article-title":"Closing the loop: the adicol experience","volume":"6","author":"Hovorka","year":"2004","journal-title":"Diabetes Technol Ther"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1211\/jpp.60.1.0001","article-title":"The future of open- and closed-loop insulin delivery systems","volume":"60","author":"Farmer","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Tamborlane","year":"2008","journal-title":"N Engl J Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1262-3636(06)72802-6","article-title":"Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system","volume":"32","author":"Renard","year":"2006","journal-title":"Diabetes Metab"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/dc07-1967","article-title":"Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas","volume":"31","author":"Weinzimer","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/jappl.1961.16.5.783","article-title":"Coefficients of normal blood glucose regulation","volume":"16","author":"Bolie","year":"1961","journal-title":"J Appl Physiol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2362.1974.tb00403.x","article-title":"A mathematical model for the glucose induced insulin release in man","volume":"4","author":"Cerasi","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"ref_12","first-page":"163","article-title":"An analogue computer model for the insulin response to glucose infusion","volume":"55","author":"Cerasi","year":"1967","journal-title":"Acta Endocrinol (Copenh)"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI110398","article-title":"Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose","volume":"68","author":"Bergman","year":"1981","journal-title":"J Clin Invest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diacare.23.2.221","article-title":"Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds","volume":"23","author":"Elbein","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_15","first-page":"E1024","article-title":"The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity","volume":"273","author":"Vicini","year":"1997","journal-title":"Am J Physiol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2007.08.017","article-title":"An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment","volume":"146","author":"Marchetti","year":"2008","journal-title":"Regul Pept"},{"key":"ref_17","unstructured":"Clarke, W.L., Larner, J., and Pohl, S. (1986). Methods of Diabetes Research, Wiley and Sons. Vol II."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0734242X04044352","article-title":"Process control in municipal solid waste incinerators: survey and assessment","volume":"22","author":"Baxter","year":"2004","journal-title":"Waste Manag Res"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1109\/TSMCB.2004.839247","article-title":"Fault tolerant control of multivariable processes using auto-tuning PID controller","volume":"35","author":"Yu","year":"2005","journal-title":"IEEE Trans Syst Man Cybern B Cybern"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/152091503322640999","article-title":"Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis","volume":"5","author":"Steil","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2166\/wst.2002.0550","article-title":"Cascade control strategy for external carbon dosage in predenitrifying process","volume":"45","author":"Cho","year":"2002","journal-title":"Water Sci Technol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0019-0578(07)60210-9","article-title":"PID controller tuning for the first-order-plus-dead-time process model via Hermite-Biehler theorem","volume":"44","author":"Roy","year":"2005","journal-title":"ISA Trans"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1088\/0967-3334\/25\/4\/010","article-title":"Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes","volume":"25","author":"Hovorka","year":"2004","journal-title":"Physiol Meas"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1210\/jc.2007-0434","article-title":"Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial","volume":"92","author":"Hovorka","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00134-008-1033-8","article-title":"Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients","volume":"34","author":"Pachler","year":"2008","journal-title":"Intensive Care Med"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/193229680700100603","article-title":"Model Predictive Control of Type 1 Diabetes: An in Silico Trial","volume":"1","author":"Magni","year":"2007","journal-title":"J Diabetes Sci and Technology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/193229680900300106","article-title":"In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes","volume":"3","author":"Kovatchev","year":"2009","journal-title":"J Diabetes Sci and Technology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0005-1098(99)00214-9","article-title":"Constrained model predictive control: Stability and optimality","volume":"36","author":"Mayne","year":"2000","journal-title":"Automatica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1525-1594.2005.29096.x","article-title":"A novel insulin delivery algorithm in rats with type 1 diabetes: the fading memory proportional-derivative method","volume":"29","author":"Gopakumaran","year":"2005","journal-title":"Artif Organs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1525-1594.2005.29024.x","article-title":"An Implantable Subcutaneous Glucose Sensor Array in Ketosis-prone Rats: Closed Loop Glycemic Control","volume":"29","author":"Ward","year":"2005","journal-title":"Artif Organs"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI111542","article-title":"Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus","volume":"74","author":"Ward","year":"1984","journal-title":"J Clin Invest"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1109\/JSEN.2007.912912","article-title":"The Benefit of Subcutaneous Glucagon During Closed-Loop Glycemic Control in Rats With Type 1 Diabetes","volume":"8","author":"Ward","year":"2008","journal-title":"IEEE Sensors"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/dia.2006.0006","article-title":"Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo","volume":"9","author":"Jiang","year":"2007","journal-title":"Diabetes Technol Ther"},{"key":"ref_34","first-page":"318","article-title":"Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia","volume":"15","author":"Taborsky","year":"2002","journal-title":"Diabetes Nutr Metab"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1109\/10.245631","article-title":"A robust controller for insulin pumps based on H-infinity theory","volume":"40","author":"Kienitz","year":"1993","journal-title":"IEEE Trans Biomed Eng"},{"key":"ref_36","unstructured":"Kaehler, S.D. Seattle Robotics Society website: http:\/\/www.seattlerobotics.org\/encoder\/Mar98\/fuz\/flindex.html."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0169-2607(96)01756-7","article-title":"Fuzzy filter for state estimation of a glucoregulatory system","volume":"50","author":"Trajanoski","year":"1996","journal-title":"Comput Methods Programs Biomed"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1109\/TBME.2006.879461","article-title":"Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route","volume":"53","author":"Femat","year":"2006","journal-title":"IEEE Trans Biomed Eng"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00449-004-0363-3","article-title":"Neural network modeling and control of type 1 diabetes mellitus","volume":"27","year":"2005","journal-title":"Bioprocess Biosyst Eng"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1056-8727(00)00137-9","article-title":"The control of blood glucose in the critical diabetic patient: a neuro-fuzzy method","volume":"15","author":"Dazzi","year":"2001","journal-title":"J Diabetes Complications"}],"container-title":["Algorithms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4893\/2\/1\/518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:10:02Z","timestamp":1760220602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4893\/2\/1\/518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,3]]}},"alternative-id":["a2010518"],"URL":"https:\/\/doi.org\/10.3390\/a2010518","relation":{},"ISSN":["1999-4893"],"issn-type":[{"value":"1999-4893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,12]]}}}